FXYD5 modulates Na+ absorption and is increased in cystic fibrosis airway epithelia

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 294, Issue 4, 2008, Pages

  Miller, Timothy J ^a   Davis, Pamela B ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Na+ K+ ATPase; Sodium transport

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DYSADHERIN; EPITHELIAL SODIUM CHANNEL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL CELL; ARTICLE; CELL STRAIN; CONTROLLED STUDY; CYSTIC FIBROSIS; DOWN REGULATION; EMBRYO; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY EPITHELIUM; SODIUM ABSORPTION; SODIUM TRANSPORT; STATISTICAL SIGNIFICANCE; TRACHEA MUCOSA; UPREGULATION;

ABSORPTION; ADOLESCENT; ADULT; ANIMALS; CELL LINE; CYSTIC FIBROSIS; DOGS; FEMALE; HUMANS; KIDNEY; LUNG; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; NEOPLASM PROTEINS; REFERENCE VALUES; RESPIRATORY MUCOSA; SODIUM;

EID: 42049110552     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00430.2007     Document Type: Article

References (41)

1. Aoki S, Shimamura T, Shibata T, Nakanishi Y, Moriya Y, Sato Y, Kitajima M, Sakamoto M, Hirohashi S. Prognostic significance of dysadherin expression in advanced colorectal carcinoma. Br J Cancer 88: 726-732, 2003.
2. Batistatou A, Charalabopoulos AK, Scopa CD, Nakanishi Y, Kappas A, Hirohashi S, Agnantis NJ, Charalabopoulos K. Expression patterns of dysadherin and E-cadherin in lymph node metastases of colorectal carcinoma. Virchows Arch 448: 763-767, 2006.
3. Batistatou A, Scopa CD, Ravazoula P, Nakanishi Y, Peschos D, Agnantis NJ, Hirohashi S, Charalabopoulos KA. Involvement of dysadherin and E-cadherin in the development of testicular tumours. Br J Cancer 93: 1382-1387, 2005.
4. Beguin P, Crambert G, Guennoun S, Garty H, Horisberger JD, Geering K. CHIF, a member of the FXYD protein family, is a regulator of Na,K-ATPase distinct from the γ-subunit. EMBO J 20: 3993-4002, 2001.
5. Boucher RC, Stutts MJ, Knowles MR, Cantley L, Gatzy JT. Na+ transport in cystic fibrosis respiratory epithelia. Abnormal basal rate and response to adenylate cyclase activation. J Clin Invest 78: 1245-1252, 1986.
6. Cohen-Luria R, Moran A, Rimon G. Cyclooxygenase inhibitors suppress inhibitory effect of PGE2 on Na-K-ATPase in MDCK cells. Am J Physiol Renal Fluid Electrolyte Physiol 267: F94-F98, 1994.
7. Cornelius F, Mahmmoud YA. Functional modulation of the sodium pump: the regulatory proteins "Fixit." News Physiol Sci 18: 119-124, 2003.
8. Davis PB, Silski CL, Kercsmar CM, Infeld M. β-Adrenergic receptors on human tracheal epithelial cells in primary culture. Am J Physiol Cell Physiol 258: C71-C76, 1990.
9. 2P conformation. Proc Natl Acad Sci USA 102: 11254-11259, 2005.
10. Fu X, Kamps MP. E2a-Pbx1 induces aberrant expression of tissue-specific and developmentally regulated genes when expressed in NIH 3T3 fibroblasts. Mol Cell Biol 17: 1503-1512, 1997.
11. Garay RP, Garrahan PJ. The interaction of sodium and potassium with the sodium pump in red cells. J Physiol 231: 297-325, 1973.
12. Garty H, Karlish SJ. Role of FXYD proteins in ion transport. Annu Rev Physiol 68: 431-459, 2006.
13. Geering K. FXYD proteins: new regulators of Na-K-ATPase. Am J Physiol Renal Physiol 290: F241-F250, 2006.
14. Ino Y, Gotoh M, Sakamoto M, Tsukagoshi K, Hirohashi S. Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis. Proc Natl Acad Sci USA 99: 365-370, 2002.
15. Jewell EA, Lingrel JB. Comparison of the substrate dependence properties of the rat Na,K-ATPase α1, α2, and α3 isoforms expressed in HeLa cells. J Biol Chem 266: 16925-16930, 1991.
16. Konstan MW, Davis PB, Wagener JS, Hilliard KA, Stern RC, Milgram LJ, Kowalczyk TH, Hyatt SL, Fink TL, Gedeon CR, Oette SM, Payne JM, Muhammad O, Ziady AG, Moen RC, Cooper MJ. Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution. Hum Gene Ther 15: 1255-1269, 2004.
17. Kyzas PA, Stefanou D, Batistatou A, Agnantis NJ, Nakanishi Y, Hirohashi S, Charalabopoulos K. Dysadherin expression in head and neck squamous cell carcinoma: association with lymphangiogenesis and prognostic significance. Am J Surg Pathol 30: 185-193, 2006.
18. +-ATPase. Am J Physiol Renal Physiol 293: F1818-F1826, 2007.
19. Lubarski I, Pihakaski-Maunsbach K, Karlish SJ, Maunsbach AB, Garty H. Interaction with the Na,K-ATPase and tissue distribution of FXYD5 (related to ion channel). J Biol Chem 280: 37717-37724, 2005.
20. + absorption produces cystic fibrosis-like lung disease in mice. Nat Med 10: 487-493, 2004.
21. Mobasheri A, Fox R, Evans I, Cullingham F, Martin-Vasallo P, Foster CS. Epithelial Na,K-ATPase expression is down-regulated in canine prostate cancer; a possible consequence of metabolic transformation in the process of prostate malignancy. Cancer Cell Int 3: 8, 2003.
22. + transport. J Gen Physiol 120: 71-85, 2002.
23. Munzer JS, Daly SE, Jewell-Motz EA, Lingrel JB, Blostein R. Tissue-and isoform-specific kinetic behavior of the Na,K-ATPase. J Biol Chem 269: 16668-16676, 1994.
24. Myerburg MM, Butterworth MB, McKenna EE, Peters KW, Frizzell RA, Kleyman TR, Pilewski JM. Airway surface liquid volume regulates ENaC by altering the serine protease-protease inhibitor balance: a mechanism for sodium hyperabsorption in cystic fibrosis. J Biol Chem 281: 27942-27949, 2006.
25. Nam JS, Kang MJ, Suchar AM, Shimamura T, Kohn EA, Michalowska AM, Jordan VC, Hirohashi S, Wakefield LM. Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells. Cancer Res 66: 7176-7184, 2006.
26. + ATPase in lower airway epithelium from cystic fibrosis and non-cystic-fibrosis lung. Biochem Biophys Res Commun 232: 464-468, 1997.
27. Perez A, Issler AC, Cotton CU, Kelley TJ, Verkman AS, Davis PB. CFTR inhibition mimics the cystic fibrosis inflammatory profile. Am J Physiol Lung Cell Mol Physiol 292: L383-L395, 2007.
28. Rajasekaran SA, Ball WJ Jr, Bander NH, Liu H, Pardee JD, Rajasekaran AK. Reduced expression of beta-subunit of Na,K-ATPase in human clear-cell renal cell carcinoma. J Urol 162: 574-580, 1999.
29. Sato H, Ino Y, Miura A, Abe Y, Sakai H, Ito K, Hirohashi S. Dysadherin: expression and clinical significance in thyroid carcinoma. J Clin Endocrinol Metab 88: 4407-4412, 2003.
30. Shimada Y, Hashimoto Y, Kan T, Kawamura J, Okumura T, Soma T, Kondo K, Teratani N, Watanabe G, Ino Y, Sakamoto M, Hirohashi S, Imamura M. Prognostic significance of dysadherin expression in esophageal squamous cell carcinoma. Oncology 67: 73-80, 2004.
31. Shimada Y, Yamasaki S, Hashimoto Y, Ito T, Kawamura J, Soma T, Ino Y, Nakanishi Y, Sakamoto M, Hirohashi S, Imamura M. Clinical significance of dysadherin expression in gastric cancer patients. Clin Cancer Res 10: 2818-2823, 2004.
32. Shimamura T, Sakamoto M, Ino Y, Sato Y, Shimada K, Kosuge T, Sekihara H, Hirohashi S. Dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness: relationship to E-cadherin expression. J Clin Oncol 21: 659-667, 2003.
33. Shimamura T, Yasuda J, Ino Y, Gotoh M, Tsuchiya A, Nakajima A, Sakamoto M, Kanai Y, Hirohashi S. Dysadherin expression facilitates cell motility and metastatic potential of human pancreatic cancer cells. Cancer Res 64: 6989-6995, 2004.
34. Shimkets RA, Lifton R, Canessa CM. In vivo phosphorylation of the epithelial sodium channel. Proc Natl Acad Sci USA 95: 3301-3305, 1998.
35. Shustin L, Wald H, Popovtzer MM. Role of down-regulated CHIF mRNA in the pathophysiology of hyperkalemia of acute tubular necrosis. Am J Kidney Dis 32: 600-604, 1998.
36. Stutts MJ, Knowles MR, Gatzy JT, Boucher RC. Oxygen consumption and ouabain binding sites in cystic fibrosis nasal epithelium. Pediatr Res 20: 1316-1320, 1986.
37. Sweadner KJ, Rael E. The FXYD gene family of small ion transport regulators or channels: cDNA sequence, protein signature sequence, and expression. Genomics 68: 41-56, 2000.
38. Tamura M, Ohta Y, Tsunezuka Y, Matsumoto I, Kawakami K, Oda M, Watanabe G. Prognostic significance of dysadherin expression in patients with non-small cell lung cancer. J Thorac Cardiovasc Surg 130: 740-745, 2005.
39. Therien AG, Nestor NB, Ball WJ, Blostein R. Tissue-specific versus isoform-specific differences in cation activation kinetics of the Na,K-ATPase. J Biol Chem 271: 7104-7112, 1996.
40. Tsuiji H, Takasaki S, Sakamoto M, Irimura T, Hirohashi S. Aberrant O-glycosylation inhibits stable expression of dysadherin, a carcinoma-associated antigen, and facilitates cell-cell adhesion. Glycobiology 13: 521-527, 2003.
41. Wu D, Qiao Y, Kristensen GB, Li S, Troen G, Holm R, Nesland JM, Suo Z. Prognostic significance of dysadherin expression in cervical squamous cell carcinoma. Pathol Oncol Res 10: 212-218, 2004.